8 completed, 3 terminated. 8 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 8 | Completed 7, Terminated 1 |
| Phase 2 | 3 | Terminated 2, Completed 1 |
Follow BMS-955176: new trials by email Literature Review of BMS-955176 trials Research Report on BMS-955176
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Effect of BMS-955176 on Pharmacokinetics of Dolutegravir and the Effect of Dolutegravir on the Pharmacokinetics of BMS-955176 Dolutegravir, BMS955176 - Infection, Human Immunodeficiency Virus | Phase 1 | Completed | ViiV Healthcare | 14 | 2016-04-01 | 2017-01-19 |
| Taste Properties of HIV Inhibitor BMS-955176 - HIV Infections | Phase 1 | Completed | ViiV Healthcare | 8 | 2016-01-05 | 2018-04-17 |
| Study on Effects of BMS-955176 on the Pharmacokinetics of Probe Substrates CYP and transporter probe substrates, BMS-955176, BMS-955176 plus CYP and transporter probe substrates - HIV Infections | Phase 1 | Completed | ViiV Healthcare | 59 | 2015-11-09 | 2018-07-13 |
| A Study to Determine the Effect of Multiple Doses of BMS-955176 on the Electrocardiograph of Healthy Subjects BMS-955176, Placebo (Part 1), BMS-955176, Moxifloxacin, Placebo (Part 2) - Infection, Human Immunodeficiency Virus | Phase 1 | Terminated | ViiV Healthcare | 315 | 2015-10-19 | 2017-08-09 |
| Strategy-confirming Study of BMS-955176 to Treat HIV-1 Infected Treatment-experienced Adults BMS-955176, Atazanavir (ATV), Ritonavir (RTV) - HIV Infections | Phase 2 | Terminated | ViiV Healthcare | 86 | 2015-07-08 | 2018-08-20 |
| Dose-finding Study of BMS-955176 to Treat HIV-1 Infected Treatment-naive Adults BMS-955176, EFV, TDF/FTC - Infection, Human Immunodeficiency Virus | Phase 2 | Terminated | ViiV Healthcare | 210 | 2015-05-12 | 2018-09-19 |
| Food Effect Study With BMS-955176 BMS-955176 - Infection, Human Immunodeficiency Virus | Phase 1 | Completed | ViiV Healthcare | 12 | 2014-10-23 | 2017-04-17 |
| Study of the Absorption, Metabolism, and Route of Elimination of a Novel Class of Anti-HIV 1 Drugs (BMS-955176) in Humans. BMS-955176 - HIV Infections | Phase 1 | Completed | ViiV Healthcare | 21 | 2014-08-08 | 2018-04-17 |
| Study of Combined Oral Contraceptive Effects in Female Subjects BMS-955176, Ortho Cyclen - Infection, Human Immunodeficiency Virus | Phase 1 | Completed | ViiV Healthcare | 46 | 2014-06-02 | 2018-04-17 |
| Relative Bioavailability Study With BMS-955176 BMS-955176 - Infection, Human Immunodeficiency Virus | Phase 1 | Completed | ViiV Healthcare | 47 | 2014-03-25 | 2017-09-11 |
| Study to Evaluate a HIV Drug for the Treatment of HIV Infection BMS-955176, Placebo matching with BMS-955176, Atazanavir - Infection, Human Immunodeficiency Virus, HIV Infections | Phase 2 | Completed | ViiV Healthcare | 107 | 2013-04-04 | 2019-11-25 |
Acquired Immunodeficiency Syndrome (7) · Infections (7) · HIV Infections (5)
ViiV Healthcare (11)
United States (7) · United Kingdom (3) · Argentina (2) · Canada (2) · Chile (2) · Germany (2) · Mexico (2) · South Africa (2) · Australia (1) · Colombia (1) · France (1) · Italy (1) · Peru (1) · Poland (1) · Puerto Rico (1)